维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Landray M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial显示文摘	Baigent C Landray M J Reith C	2011	The Lancet2011，377，9784：	1
2	Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study 显示文摘	Landray M J Wheeler D C	2004	Am J Kidney Dis2004，43，2：	1
3	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study Of heart and renal protection): a randomised placebo-controlled trial 显示文摘	Baigent C Landray M J Reith C	2011	Lancet2011，377，9784：	1
4	The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD 显示文摘	LANDRAY M BAIGENT C LEAPER C	2006	Am J Kidney Dis2006，47，3：	1
5	Neprilysin inhibition in chronic kidney disease显示文摘	JUDGE P HAYNES R LANDRAY M J	2014	Nephrol Dial Transplant2014，18，：	1
6	Analysis of cancer data from three ezetimibe trials显示文摘	Peto R Emberson J Landray M	2008	N Engl J Med2008，359，：	1
7	Association of atherogenic low-density lipoprotein subfractions with carotid athersclerosis 显示文摘	Landray M J Sagar G Muskin J	1998	Q J Med1998，91，：	1
8	The effects of lowering LDL cholesterol with simvastati plus ezetimibe in patients with chronic kidney disease ( Study of Heart and Renal Protection) : a randomised placebo - controlled trial 显示文摘	Baigent C Landray M J Reith C	2011	Lancet2011，377，：	1
9	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection):a randomised placebo-controlled trial显示文摘	Baigent C Landray M J Reith C		0，，9784：	1
10	Effects of extended- release niacin with laropiprant in high-risk patients 显示文摘	Landray M J Haynes R Hopewell JC	2014	N Engl J Med2014，371，3：	1
11	Effects of extended-release niacin with laropiprant in high-risk patients显示文摘	HPS2-THRIVE Collaborative Group Landray M J Haynes R	2014	N Engl J Med2014，371，3：	1
12	Homocysteine,renal function,and risk of cardiovascular disease显示文摘	Clarke R Lewington S Landray M		0，，84：	1
13	The effects of lowering LDL cholesterolwith simvastatin plus ezetimibe in patients with chronic kidney disease (Studyof Heart and Renal Protection): a randomised placebo-controlled trial显示文摘	Baigent C Landray M J Reith C	2011	TheLancet2011，377，9784：	1
14	First United Kingdom Heart and Renal Protection(UK-HARP-I)study:biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease显示文摘	Baigent C Landray M Leaper C	2005	Am J Kidney Dis2005，45，：	1
15	Effects of extended-release niacin with laropiprant in high-risk patients显示文摘	GROUP H T C LANDRAY M J HAYNES R	2014	N Engl J Med2014，371，：	1
16	The effects of lowering LDLcholesterol with simvastatin plus ezetimibe in patients with chronickidney disease (study of heart and renal protection): a randomisedplacebo-controlled trial显示文摘	Baigent C Landray M J Reith C	2011	Lancet2011，377，9784：	1
17	Effects of extended -release niacin with laropiprant in high-risk patients 显示文摘	Landray M J Haynes R Hopewell JC	2014	N Engl J Med2014，371，3：	1
18	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection) : a randomised placebo-controlled trial 显示文摘	BAIGENT C LANDRAY M J REITH C	2011	Lancet2011，377，9784：	1
19	First United Kingdom Heart and Renal Protection(UK-HARP-I)study:biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease显示文摘	Baigent C Landray M Leaper C	2005	Am J Kidney Dis2005，45，3：	1
20	First United KingdomHeart and Renal Protection (UK-HARP-I) study: biochemicalefficacy and safety of simvastatin and safety of low-dose aspirinin chronic kidney disease显示文摘	Baigent C Landray M Leaper C	2005	Am J Kidney Dis2005，45，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示